HappeningToo topic
Dapagliflozin reports
Browse community reports connected to Dapagliflozin. These reports can show that other people are describing similar experiences, but they do not prove that Dapagliflozin caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
34 problems
Abdominal Discomfort while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and abdominal discomfort appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and abdominal pain upper appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and abdominal pain appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and alopecia appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and anxiety appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and back pain appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and decreased appetite appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and dehydration appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and diarrhea appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and dizziness appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and dry skin appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and excessive sweating appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and fatigue appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and feeling abnormal appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and headache appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and heart rate increased appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and hypotension appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and insomnia appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and itching appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and malaise appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and migraine appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and muscular weakness appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and nausea appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and pain appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and palpitations appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and peripheral swelling appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and rash appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and shortness of breath appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and sleepiness appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tachycardia while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and tachycardia appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tinnitus while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and tinnitus appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and vomiting appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and weakness appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Dapagliflozin
FDA FAERS contains adverse-event reports in which Dapagliflozin and weight decreased appear together. This does not establish that Dapagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →